These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10417540)
1. Porokeratosis in patients with hepatitis C virus infection: does hepatitis C virus infection provide a link between porokeratosis and immunosuppression? Mizukawa Y; Shiohara T Br J Dermatol; 1999 Jul; 141(1):163-4. PubMed ID: 10417540 [No Abstract] [Full Text] [Related]
2. Hyperkeratotic variant of porokeratosis in a patient with Hepatitis C virus infection and a concomitant immunosuppressed state. Parekh V; Kabihting FD; Junkins-Hopkins JM Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632932 [TBL] [Abstract][Full Text] [Related]
3. [Eruptive disseminated superficial porokeratosis associated with acute hepatitis E]. Dumas M; Corre F; Payancé A; Guedj N; Durand F; Descamps V; Le Bozec P Ann Dermatol Venereol; 2019 Oct; 146(10):655-658. PubMed ID: 31326131 [TBL] [Abstract][Full Text] [Related]
4. Porokeratosis in immunosuppressed and nonimmunosuppressed patients. Raychaudhuri SP; Smoller BR Int J Dermatol; 1992 Nov; 31(11):781-2. PubMed ID: 1428428 [TBL] [Abstract][Full Text] [Related]
5. Onset of porokeratosis of Mibelli in organ transplant recipients: lack of a search for transmissible agents in these patients. Mizukawa Y; Shiohara T J Am Acad Dermatol; 2001 Jan; 44(1):143-4. PubMed ID: 11148495 [No Abstract] [Full Text] [Related]
7. [Squamous cell carcinoma and disseminated superficial actinic porokeratosis]. Rémond B; Dompmartin A; Mandard JC; Leroy D Ann Dermatol Venereol; 1994; 121(1):50-2. PubMed ID: 8092731 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: experience with kidney transplantation. Torres J; Aguado JM; San Juan R; Andrés A; Sierra P; López-Medrano F; Morales JM Transpl Int; 2008 Sep; 21(9):873-8. PubMed ID: 18482173 [TBL] [Abstract][Full Text] [Related]
9. High incidence of porokeratosis in renal transplant recipients. Herranz P; Pizarro A; De Lucas R; Robayna MG; Rubio FA; Sanz A; Contreras F; Casado M Br J Dermatol; 1997 Feb; 136(2):176-9. PubMed ID: 9068727 [TBL] [Abstract][Full Text] [Related]
10. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502 [TBL] [Abstract][Full Text] [Related]
11. Are porokeratoses an infection? Webster GF Arch Dermatol; 2001 May; 137(5):665. PubMed ID: 11346352 [No Abstract] [Full Text] [Related]
12. Fatal acute hepatitis C virus infection in patients with hematological malignancies. Taliani G; Tozzi A; Fanci R; Biliotti E; Bosi A J Chemother; 2006 Dec; 18(6):662-4. PubMed ID: 17267347 [TBL] [Abstract][Full Text] [Related]
13. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512 [TBL] [Abstract][Full Text] [Related]
14. Porokeratosis of Mibelli induced by topical corticosteroid. Yazkan F; Turk BG; Dereli T; Kazandi AC J Cutan Pathol; 2006 Jul; 33(7):516-8. PubMed ID: 16872477 [TBL] [Abstract][Full Text] [Related]